The antibody specifically binds to CD38 which is capable of killing CD38+ cells through apoptosis, antibody-dependent cell-mediated cytotoxicity, and complement-dependent cytotoxicity. The antibody may be used as a medicament or in making a medicament to treat humans with a safe therapeutic dose and targets CD38+ multiple myeloma. The antibody is a humanized IgG1 clone named Hu38SB19 derived from human sources for functional assays and research use only.

1. cd38 antibody
• The present antibody specifically binds to CD38 which is capable of
killing a CD38+ cell by induction of apoptosis, antibody-dependent
cell- mediated cytotoxicity (ADCC), and complement-dependent
cytotoxicity. The disclosed antibody may be used as a medicament or
in the making of a medicament, wherein the antibody is to be
administered to a human subject in a safe therapeutic dose.

2. • Specifications
• HostHuman
• DerivationHumanized
• TypeHumanized IgG1
• SpecificityHuman CD38
• Species ReactivityHuman
• CloneHu38SB19
• ApplicationsFunctional Assay
• Related DiseaseCD38+ multiple myeloma
• Target
• Alternative NamesCD38 Molecule; ADP-Ribosyl Cyclase 1; 2-Phospho-Cyclic-ADP-Ribose Transferase; Cyclic ADP-Ribose Hydrolase 1; 2-
Phospho-ADP-Ribosyl Cyclase; NAD(+) Nucleosidase; CD38 Antigen (P45); ADPRC 1
• Entrez Gene ID952
• UniProt IDP28907

3. • For lab research use only, not for diagnostic, therapeutic or any in
vivo human use.